Total Funding
57
5
Total FundingVenture - Series Unknown raised
Growth Score
-5 pts
Heat Score
-33 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
105374
Emergo Therapeutics is a pharmaceutical startup that develops treatment options for flu-like illnesses.
Karen Adams: CFOPast Role: Target PharmaSolutions, CFO
Robin Hyde-DeRuyscher: Founder & CSO
About the Company
Emergo Therapeutics is a pharmaceutical startup that develops treatment options for flu-like illnesses. It is focused on developing drugs to modulate inflammatory cytokines and improve the functioning of the immune system in various potential indications, starting with infectious diseases. Emergo’s therapeutic interventions are focused on reducing
the production of inflammatory cytokines from mast cells.
Emergo is headquartered in Durham, North Carolina.
